Chemical formula: C₂₅H₂₇ClN₂ Molecular mass: 390.948 g/mol PubChem compound: 4034
Meclizine is a first generation antihistamine that is used largely to treat vertigo and motion sickness.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R06AE05 | Meclozine | R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AE Piperazine derivatives |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| MECLIZINE HYDROCHLORIDE Tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Meclozine is an active ingredient of these brands:
United States (US)
Finland (FI)
France (FR)
Hong Kong (HK)
Malta (MT)
Mexico (MX)
New Zealand (NZ)
Romania (RO)
Spain (ES)
Tunisia (TN)
Turkey (TR)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
